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Clenbuterol hydrochloride (CLB) is a growth-promoting b-agonist in animals for sup-
ply, but its illicit use has generated repercussions on public health. A biological model 
with mice was developed to evaluate the effect of CLB on weight gain and histological 
lesions. Mice were fed rabbit meat, which was previously supplemented with CLB. Body 
weight was recorded 35 days post-exposure; muscular and serum concentration of CLB 
was obtained through the ELISA test, and tissues were collected from liver and heart for 
histopathological analysis. Values obtained from the experimental animals (G1 and G2) 
were analyzed by a completely randomized experimental design with two treatments 
(n = 10), subjected to an analysis of variance and comparison of means with the Tukey 
test (p < 0.05). There was an increase of 7 g in body weight in G1, compared to 4.0 g in 
G2. Liver weight was 2.58 g and 1.79, respectively (p < 0.05). In G1, CLB concentration 
in muscle was 5324 pg.g–1, and 4378 pg.g–1 in blood serum. Only histological changes 
were observed in the tissues of G1 mice. Liver showed cellular swelling, moderate mi-
tosis, pyknosis and hydropic degeneration; in addition, fiber thickening, pleomorphism 
and nuclear atypia were observed in the heart. CLB contributed to weight gain in ex-
posed mice and caused structural alterations in liver and heart.
Keywords: clenbuterol hydrochloride, toxicity, mice, ELISA.
Efecto del clorhidrato de clembuterol en la ganancia  
de peso y lesiones histológicas en ratones
Resumen 
El clorhidrato de clembuterol (CCL) es un b-agonista promotor del crecimiento en ani-
males para abasto, pero su uso ilícito ha generado repercusiones en salud pública. Se rea-
lizó un modelo biológico con ratones, con el objeto de evaluar el efecto del CCL sobre la 
ganancia de peso y las lesiones histológicas que ocasiona. Los ratones fueron alimenta-
dos con carne de conejo, que previamente fue suplementada con CCL. Treinta y cinco 
días posexposición se registró el peso corporal; se obtuvo la concentración muscular y 
sérica de CCL a través de la prueba de ELISA, y se colectaron tejidos (hígado y corazón) 
para análisis histopatológico. Los valores obtenidos de los animales experimentales (G1 
y G2) se analizaron mediante un diseño experimental completamente al azar con dos 
tratamientos (n = 10), sometidos a un análisis de varianza y comparación de medias con 
la prueba de Tukey (p < 0,05). Se registró un incremento de peso corporal de 7 g en el G1, 
contra 4,0 g del G2. El peso del hígado fue de 2,58 g y 1,79, respectivamente (p < 0,05). 
En el G1 la concentración muscular de CCL fue 5324 pg g–1 y en suero sanguíneo de 4378 
pg g–1. Solo se observaron cambios histológicos en tejidos de los ratones del G1. El hígado 
doi: http://dx.doi.org/10.19052/mv.4395
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mostró tumefacción celular, mitosis moderada, picnosis y degeneración hidrópica; en 
corazón, engrosamiento de fibras, pleomorfismo e hileración nuclear. El CCL favoreció 
el incremento de peso en los ratones expuestos, y provocó alteraciones estructurales en 
hígado y corazón.
 
Palabras clave: clorhidrato de clenbuterol, ELISA, toxicidad, ratones (Fuente: MeSH).
Efeito do cloridrato de clembuterol no aumento de peso  
e lesões histológicas em ratos
Resumo
O cloridrato de clembuterol (CCL) é um b-agonista promotor do crescimento em ani-
mais para abate, porém o seu uso ilícito tem gerado repercussões em saúde pública. Fez-
-se um modelo biológico com ratos, com o objeto de avaliar o efeito do CCL sobre o 
ganho de peso e as lesões histológicas que ocasiona. Os ratos foram alimentados com 
carne de coelho, que previamente foi suplementada com CCL. Trinta e cinco dias pós-
-exposição se registrou o peso corporal; obteve-se a concentração muscular e sérica 
de CCL através da prova de ELISA, e foram coletados tecidos (fígado e coração) para 
análise histopatológica. Os valores obtidos dos animais experimentais (G1 e G2) foram 
analisados mediante um desenho experimental completamente ao acaso com dois tra-
tamentos (n = 10), submetidos a uma análise de variações e comparação de médias com 
a prova de Tukey (p < 0,05). Registrou-se um aumento de peso corporal de 7 g no G1, 
contra 4,0 g do G2. O peso do fígado foi de 2,58 g e 1,79, respectivamente (p < 0,05). No 
G1 a concentração muscular de CCL foi 5324 pg g–1 e em soro sanguíneo de 4378 pg g–1. 
Somente foram observadas mudanças histológicas em tecidos dos ratos do G1. O fígado 
apresentou inchaço celular, mitose moderada, picnose e degeneração hidrópica; no cora-
ção, engrossamento de fibras, pleomorfismo e filamento nuclear. O CCL favoreceu o au-
mento de peso nos ratos expostos, e provocou alterações estruturais em fígado e coração.
Palavras chave: cloridrato de clembuterol, toxicidade, ratos, ELISA.
CLB causes hypertrophy and muscle neoformation by 
means of glycogenolysis—nitrogen accumulation for 
amino acid conformation—and glycolysis—fat deg-
radation—, which increases the size of muscle cells, 
mainly in skeletal muscle (6-8). Its growth-promoting 
effect is mediated by direct stimulation of b2 adrener-
gic receptors located in the muscle tissue and variation 
in plasma concentrations of catabolic or anabolic hor-
mones, such as glucocorticoids, growth hormone or 
insulin (9,10).
Introduction
Clenbuterol hydrochloride (CLB) [4-Amino-alpha-
[(tert-butylamino)methyl]-3,5-dichlorobenzyl alcohol 
hydrochloride] is a synthetic β-adrenergic agonist, 
white or slightly yellow, with a molecular weight of 
313.65 (1-3). It is used as a bronchodilator in human and 
veterinary medicine. Its use as an anabolic agent main-
ly in cattle is currently illegal. It has been shown to in-
crease protein synthesis by up to 15%, and to decrease 
body fat deposition by 18% (4,5).
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The effect of CLB on the endocrine system occurs by 
hormone release through catecholamines, which re-
lease insulin, increase glucagon and stimulate the re-
lease of adrenocorticotropic hormone, somatotropin, 
and gonadotropin. This decreases fat deposition by 
increasing metabolic activity and energy expenditure 
with increased thermogenesis; part of the ingested en-
ergy prevents fat formation by increasing the level of 
cyclic adenosine monophosphate (AMP) in the adi-
pose tissue. Adenosine triphosphate (ATP) is con-
verted into cyclic AMP that activates protein kinases, 
which, by phosphorylation, stimulate an intracellular 
lipase that transforms triglycerides into fatty acids and 
glycerol (9-11).
Although the use of CLB has been banned in several 
countries, including Mexico (3,12), its clandestine ad-
ministration in the feeding of cattle has been a public 
health problem worldwide (3,5,11,13,14), due to the 
consumption of meat and viscera (liver) contaminated 
with this substance. This causes pathological processes 
in humans, manifested by muscular tremor, excessive 
sweating, limb numbness, headache, and tachycardia 
(8,15).
The study and analysis by Jiménez et al. (16) report-
ed 2130 cases of CLB intoxication in Mexico between 
2002 and 2008. Jalisco, the Federal District, Guanajua-
to, Zacatecas and Michoacán registered the most cases. 
Jalisco was the state with the highest number of cases 
(35.25%), followed by the Federal District (23.94%), 
and cases per year had increased significantly. How-
ever, the study did not report the levels detected in af-
fected patients neither did it establish the dose patients 
were exposed to and which caused abnormality. Like-
wise, possible histological lesions in tissues where CLB 
can accumulate have not been evaluated. Thus, the ob-
jective of this study was to evaluate the effect of CLB 
on weight gain and histopathological alterations in the 
liver and heart of mice exposed to rabbit meat contami-
nated with CLB as the sole source of food.
Materials and methods
Prior to this study, a biological model was designed, in 
which rabbits were given CLB (in “mineral salt” form) 
diluted in drinking water at a dose of 16 mg/kg of CLB 
(1.1815 mg/L/day), for a period of 35 days, at the end of 
which they were sacrificed. All muscle tissue was col-
lected and its CLB concentration was determined to be 
7619 pg g–1.
Experimental animals
For this research, 20 6-weeks old male BALB/c4 mice 
were used; they were placed in individual cages comply-
ing with comfort and animal welfare conditions. The 
research complied with the ethical, technical, scientific, 
and administrative guidelines of the Ministry of Agri-
culture, Livestock, Rural Development, Fisheries and 
Food (SAGARPA) (17) for animal research.
Experimental procedure
Mice were randomly distributed into two groups (G1 
and G2); both groups received rabbit meat (dehydrated 
at 80°C) as their sole source of food, at a rate of 3.5 g per 
day, and distilled water on free demand, as follows:
G1: rabbit meat containing 7619 pg g–1 of CLB (n = 10).
G2: control group, rabbit meat with 0 residues of CLB 
(n=10).
Sample collection and processes 
performed
Thirty-five days after initiating the experiment, the 
weight of the mice was measured. They were sacrificed 
according to the guidelines established by SAGARPA 
(18), and the whole blood was collected in tubes with-
out anticoagulant. An anatomical-pathological study 
was performed to evaluate macroscopic changes; liver 
and heart samples were collected and fixed in 10% buff-
ered formalin (10:1). Hematoxylin-eosin staining was 
used for histological evaluation.
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The ELISA test
CLB concentrations were obtained using the ELISA 
test (RIDASCREEN® Clenbuterol Fast, R-Biopharm 
AG, Darmstadt, Germany), using 20 ml of stratum from 
the muscle tissue sample or blood serum. Absorbances 
were read with a 450 nm filter in a BioTek plate reader, 
and the values obtained were expressed as pg g–1 (11,19).
Data analysis
For result analysis, a one-way analysis of variance was 
performed using a completely randomized design, in 
which treatment was considered as the main source of 
variance, with two treatments of 10 experimental units 
in each. Tukey’s multiple comparison test (p<0.05) was 
applied to the variables that showed significant differ-
ences (20).
Changes observed in the anatomical-pathological and 
histological studies of tissues and organs collected from 
the two groups were evaluated qualitatively and by as-
sessment based on the degree of alteration in each tis-
sue, as described by Ke et al. (21).
Results and discussion
In the applied biological model, after the inclusion of 
meat with a CLB concentration of 7619 pg g–1 for G1 and 
0 residues of CLB for G2 as the sole source of food, G1 
animals showed a greater increase in body weight than 
G2 mice (p < 0.05) (Table 1).
the exact concentration, it has been reported that the 
consumption of meat contaminated with a “moderate” 
dose of CLB produces numbness in hands, muscular 
tremors, nervousness, and headaches, while at “higher” 
doses, it results in tachycardia, which can lead to myo-
cardial necrosis (14,23,24).
In the immunoenzymatic assay, mean serum concentra-
tions of CLB were 0.00 pg g–1 and 4378 ± 437.57 pg g–1 
for G 2 and G 1, respectively (p<0.05). Blood serum and 
urine should be used to detect CLB in animals for supply 
prior to slaughter, which would allow for a quarantine 
period necessary for possible elimination (7,11). Due to 
the prolonged use of CLB in different species for supply 
(cattle, pigs and poultry), the presence of this substance 
can be detected in the retina, hair, and feathers, due to 
its affinity for melanin found in these structures, which 
has an indicative value for its illegal use (8,25).
Due to the presence of CLB in the muscle tissue of rab-
bits that were fed to mice and the subsequent detection 
of CLB in the muscle of these mice (5324 pg g–1), it was 
possible to confirm the capacity of CLB for biological 
retention and deposition in white tissues. It has been es-
tablished that the residence time and kinetics of CLB in 
blood serum can be determined over a period of four to 
six days, which will continue with detectable concentra-
tions depending on the dose and administration time. 
This represents a risk factor of intoxication for consum-
ers, as observed in the food chain of this experiment 
with the administration of CLB-contaminated meat. 
At this point, it is important to consider the particular-
ity of the chemical structure of CLB (chlorine content), 
given its residence time in consumable tissues, which is 
56 to 60 days in the liver and six days in the muscle tis-
sue (25). 
Furthermore, the results obtained support that CLB is a 
stable particle at dehydration temperature (80°C), with 
a prolonged action. According to the Codex Alimentari-
us (26), which establishes a concentration of 2000 pg g–1 
as the “maximum residue limit” for CLB in blood serum, 
the detected values of CLB in G1 mice are considered 
high. This confirms the accumulation capacity of this 
Strydom et al. (22) evaluated growth performance and 
carcass characteristics in cattle after supplying dif-
ferent b-agonists (zilpaterol, ractopamine, and CLB) 
and found better feed conversion and weight gain with 
lower fat deposition in the carcasses of CLB-treated 
animals compared to the control group (p < 0.05), fol-
lowed by animals treated with zilpaterol. However, it 
has been shown that the eating of CLB-contaminated 
meat produces adverse effects on human health, due to 
cardiovascular system stimulation. Without recording 
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substance in the food chain and its residual effect, given 
that the experimental animals were the second link in 
the food chain.
At necropsy, no evident macroscopic lesions were ob-
served in the animals of the two treatment groups, ex-
cept for increased muscle mass with lower fat deposition 
in G1 mice. The mean liver weight was 1.79 g and 2.58 g 
for G2 and G1 mice, respectively (p < 0.05).
The histopathological study of heart muscle in G1 
mice showed muscle fiber thickening (10 of 10), pleo-
morphism and nuclear swelling (Figure 1). In the liv-
er of CLB-treated animals, the observed lesions were 
tumefaction and moderate-to-diffuse hydropic degen-
eration, mitosis, pyknosis, and megalocytosis with he-
patocyte megakaryosis (Figure 2).
Figure 1. Histological cut of heart muscle from G1 mice, 
evidence of muscular hypertrophy denoted by pleomorphism 
and nuclear swelling, as well as fiber thickening (arrows). 
Staining: Hematoxylin and eosin. 10X
Table 1. Weight of mice (BALB/c4) after administration of CLB-contaminated meat 
Group Initial weight (g) Final weight (g) Body weight gain (g)
G1 (7619 pg g-1 of CLB) 18.0a ± 0.52 25.0a ± 0.52 7.0a
G2 (Control: 0 residues) 18.1a ± 0.51 22.1b ± 0.50 4.0b
Different letters per column indicate values that statistically differ (Tukey, p < 0.05).
Figure 2. Histological cut of liver from G1 mice, evidence of 
swelling and moderate hydropic degeneration, mitosis and 
hepatocyte pyknosis (arrows). Staining: Hematoxylin  
and eosin. 20X
The changes observed in heart muscle are consistent 
with that reported by Van Vleet and Valentine (27), who 
consider fiber swelling and thickening as a process of 
muscular hypertrophy, which was consistently present 
only in CLB-treated animals. The alterations observed 
in heart suggest that CLB acts on specific b2-type recep-
tors localized in this tissue, inducing structural chang-
es, and its effect is greater on skeletal muscles (23,28). 
Based on its chemical structure, the action of CLB has 
been related to catecholamine action, capable of inter-
acting with b2-type adrenergic receptors, activating the 
GS protein system associated with adenylyl cyclase, 
which plays an important role in the entry of calcium 
into the cell and intervenes in cellular protein synthesis 
(3,6,29).
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In the liver of mice exposed to CLB (10 of 10), signifi-
cant alterations were observed, evidencing the toxic ef-
fect of CLB (10,28). CLB has a prolonged action in the 
organism; it is stored mainly in liver and kidney and is 
metabolized into hydroxyclenbuterol and glucuronic 
conjugates by N-oxidation reactions (13,28). Zalco, Bo-
ries and Tulliez (29) report that CLB metabolites, such 
as N-hydroxylamine and N-nitroso clenbuterol, have 
toxic properties that are hazardous for both animal and 
human health.
Badino, Odore and Re (9), after administering 30 and 
50 μg of CLB/kg/day to rabbits, observed fetotoxic ef-
fects (delayed ossification and cleft palate). Another 
study reports that the possible toxic effect is mainly due 
to an effect of adrenergic stimulation, rather than to a 
genotoxic effect (30).
No apparent symptoms were observed in animals un-
der treatment (except for increased activity or some 
nervousness). However, the intoxication symptoms 
presented by two patients after eating liver and meat 
contaminated with CLB, reported by Carrola et al. 
(31), were muscle tremor, nausea, and incoordination. 
At auscultation, patients showed increased heart rate 
(90/min), increased blood pressure (140/80 mmHg), 
while hematological examination evidenced leukocyto-
sis (12.1-12.2 × 109 L-1), accompanied by neutrophilia 
(9.3-10.1 × 109 L-1), hyperkalemia (2.7-2.8 mmol L-1), 
and hyperglycemia (9.5-12.1 mmol L-1).
In bovines, and perhaps in other species for supply, the 
clandestine and irrational use of CLB continues to oc-
cur in an alarming way (3,11,29,31). Therefore, regu-
lations must be updated and applied for the benefit of 
public and animal health. Similarly, permanent pro-
grams must be implemented to monitor, control and 
eradicate the use of this substance, while proposing al-
ternatives (32) for good animal production practices.
Conclusions
Using a CLB concentration three times higher than the 
maximum limit established as toxic, a greater weight 
gain was observed in mice that were exposed to CLB-
contaminated meat. CLB favors weight gain in mice; 
however, the histopathological alterations observed in 
liver show a hepatotoxic effect.
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